13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SC Filed 2020-01-24 Event — SEC 0001104659-20-006801 →

BAKER BROS. ADVISORS LP BELLICUM PHARMACEUTICALS, INC

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
65 filings by this filer
64 other filings in the data moat
Short Interest
Not in latest FINRA snapshot

Other Filings by BAKER BROS. ADVISORS LP

FiledFormIssuerStakeShares
2026-08-11 SCHEDULE 13D/A Replimune Group, Inc. 11.80% 11,075,336 view →
2026-07-16 SCHEDULE 13D/A Celcuity Inc. 9.99% 4,877,963 view →
2026-07-16 SCHEDULE 13G Celcuity Inc. view →
2026-06-15 SCHEDULE 13D/A BeOne Medicines Ltd. BEIGF 8.00% 115,457,154 view →
2026-05-26 SCHEDULE 13D/A Kiniksa Pharmaceuticals International, plc KNSA 7.00% 3,231,181 view →
2026-05-11 SCHEDULE 13D/A Incyte Corp INCY 30,865,077 view →
2025-06-30 SCHEDULE Kymera Therapeutics, Inc. KYMR 9.50% 6,666,540 view →
2024-10-08 SC Kiniksa Pharmaceuticals International, plc KNSA view →
2024-06-14 SC INCYTE CORP INCY view →
2023-12-18 SC Seagen Inc. view →
2023-10-10 SC Neoleukin Therapeutics, Inc. NGNE view →
2023-10-05 SC MADRIGAL PHARMACEUTICALS, INC. MDGL view →
2023-07-19 SC Neoleukin Therapeutics, Inc. NGNE view →
2023-05-24 SC Prelude Therapeutics Inc PRLD view →
2023-05-24 SC ACADIA PHARMACEUTICALS INC ACAD view →
2023-05-03 SC Seagen Inc. view →
2023-03-15 SC INCYTE CORP INCY view →
2023-03-13 SC Seagen Inc. view →
2023-01-17 SC ACADIA PHARMACEUTICALS INC ACAD view →
2022-07-20 SC Immunocore Holdings plc IMCR view →
Showing 20 of 64

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →